OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery
Artificial intelligence powerhouse OpenAI Group PBC is lending its expertise to Novo Nordisk A/S in a new partnership announced today that aims to accelerate research in the pharmaceutical industry. The sweeping collaboration will see OpenAI’s intelligent agents embedded across the drug maker’s workflows in order to enhance everything from lab-based drug discovery to the complexities […] The post OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery appeared first on...
Original Source
Read the full article at Siliconangle →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.